Token Count
1 ATL = 0.0001 ETH

Quality of services

Poor quality of services provided to the population by medical institutions and doctors.

Due to the lack of qualified medical personnel as well as medical diagnostic tools medical centers are often unable to correctly and timely diagnose patients and prescribe the necessary quality pharmaceuticals, these actions entail serious consequences and in some cases, grave consequences including death.

Alternative choice

Patients are unable to choose medical centers and doctors by analyzing the services provided

Patients do not have the opportunity to choose a medical center and a doctor due to the lack of opportunity to conduct an assessment and compare a medical center or a doctor, and make the right decisions where to go for timely and necessary assistance.

Also, we must not forget that insurance companies limit patient, doctor and medical center in the choice of pharmaceuticals, diagnostic tools that deprive patient of the freedom of choice, and limits doctor and medical center in the possibility of providing high quality services

Counterfeit drugs

Availability of counterfeit drugs on the market

Nowadays, there are no methods of combating the production and distribution of counterfeit medical pharmaceutical products which entails serious consequences for the life and health of people. At the moment on the market there is no clearly exhibited logistics supply chain for tracking medical-pharmaceutical products and the subsequent provision to patients through pharmacies and companies engaged in wholesale trade of pharmaceutical products. It is important to remember that most of the counterfeit pharmaceutical products are sold through pharmacy chains and companies engaged in wholesale of pharmaceutical products.

High price

The presence of inflated prices for medical and pharmaceutical products and services.

Nowadays, prices of medical and pharmaceutical products are not regulated on the market, that's why consumers have to buy medical pharmaceutical products at inflated prices. This happens because a group of intermediaries has formed in the logistics and retail chain of the market which operate within the framework of the market economy adding their mark-up to the goods.

Insurance fraud

The presence of unscrupulous doctors and medical centers that illegally charge money from insurance companies.

Very often there is a practice of falsifying insurance cases on the part of doctors and medical centers to get insurance payments. It is not always possible to track and prevent this, causing huge damage to insurance companies and reducing the quality of insurance services provided to the people. Thus causing both financial and reputational harm to the insurance company.

Our mission

Organize remote and secure interaction in the market of medical and pharmaceutical products and services. Build transparent relationships without risks to improve the level of medical and pharmaceutical services.

Wholesale sellers<br>of pharmaceutical products

The most important component in the business of selling pharmaceutical products is the quality and quantity of sales. This platform allows increasing the company's revenue, expand work with pharmacy chains, build a more robust chain from the manufacturer of pharmaceutical products to the end user


It is important for each doctor to provide the patient with high-quality help to prescribe quality pharmaceuticals so that the patient is satisfied.

Medical center

For each medical center it is important to have high-quality and professional staff as well as medical and diagnostic equipment that meets all the modern requirements in clinics and hospitals. Services must be available to the public and have positive ratings of their work by patients.

Manufacturers of pharmaceutical goods

This platform allows manufacturers of pharmaceutical products to clearly track the path of the produced drug to the end user, thereby eliminating the possibility of producing counterfeit pharmaceuticals. Thanks to the analysis the pharmaceutical manufacturer is evaluated by the consumer and has the opportunity to improve the quality of products and remain competitive on the market.


For pharmacy chains it is important to have on sale high-quality, genuine, in-demand products purchased at more flexible prices, thereby attracting an additional flow of buyers


It is important for each patient to have proven and affordable medical services, starting from the doctor who diagnoses and up to manufacturers of pharmaceutical products so that in this chain of interactions all links are at the highest level at the best prices, regardless of the geographical location of patients.

Insurance companies

For each insurance company it is important to avoid being deceived by medical centers and medical professionals - each insured event must be auditable so that insurance companies do not suffer losses.

The mobile app for interacting with the platform

  • Easy search and selection of medical centers, doctors or pharmacies located nearby
  • Analysis based on patient comments and ratings
  • Quality control of purchased pharmaceutical products
  • Ability to evaluate the quality of pharmaceutical products and services
  • Evaluation of insurance policies sold by companies as well as their service


Stephane Deceulener


Businessman with many years of experience in the successful creation and development of businesses from scratch. Since 1982, he has established and developed businesses in the direction of real estate construction and sales in Spain, restaurant business in California and Spain, at the moment is the founder of the energy trading company in Spain SOLELEC IBERICA S. L.

Bernard Patrick Dobson

Financial director

British born Certified Accountant has a long career working mainly for Middle Eastern and US multinational companies in over a dozen different countries across 4 continents. Most recently he was engaged by one of the world's foremost sovereign wealth funds but now operates as an independent consultant on all matters financial and has been the chief third party advisor to Atlantic for the last two years.

Alain Marc Duriaux


Institute of Diffusion-Bruxel communications 1970 - 1972 The military service , License of Gentleman Rider Royal Jockey club of Belgium, 1974 Cooperation with Amerf Salud Africa 2015 Legal support from 2000 to the company Mayors 2000SL Legal support since 2013 of the energy trading company in Spain SOLELEC IBERICA S. L.

Jose Pernia Calderon

Representative in Spain for development and scaling of the platform

1985-1989 - Vice Mayor of Marbella, Spain, Founding partner of the company M95TV MARBELLA.

Murat Ibragimov

Representative in Russia for development and scaling of the platform

Cardiologist , doctor medicine. Working place: A.N. Bakulev National Medical Research Center of Cardiovascular Surgery


  • June 1987

    The launch of Atlantic International Finance and Loan Limited Company.

  • 1990 -1997

    Restaurant business, a catering company and Palm Desert restaurant, California, USA .

  • 1997 - 2016

    Work in financial and real estate industries in Belgium .

  • 1997 - 2007

    Work in real estate industry in Costa del Sol.

  • 1997 -2004

    Work in the restaurant business in Costa del Sol.

  • 2007

    Sale of 80% of real estate, mostly in the areas of Puerto Banus (Marbella) and San Pedro De

    Alcantara (Marbella).

  • 2007-2014

    Work in the restaurant business in Belgium, launch of the best restaurant Le Borse cafe, place

    Albert Chiffrer № 1, Nivelles 1400, Belgium.

  • 2016

    Sale of 100% of real estate in Belgium. Mostly in Nivelles.

  • October2013

    Creation of an energy company Solelec iberica that works with the largest medical centers in

    Costa Del Sol and Marbella (Spain), such as Xanit International Hospital Benalmadena and

    Marbella International Hospital .

  • July 2016 - June 2017

    Development of the concept and reaching out to potential partners of the company

  • January - May 2018

    Creating a team to realise the project.

  • June 2018

    Creating a demo version of the platform and the mobile app, filing a patent application in the

    British Overseas Territories and Crown Dependencies, EU and USA.

  • July 2018

    Signing a preliminary agreement with Ministries of Health of Ukraine and South Africa on

    testing the platform in state medical centers.

  • July 2018

    Token Pre-Sale .

  • August - October 2018


  • November 2018

    Listing of tokens on cryptocurrency exchanges.

  • December 2018 - January 2019

    Launch of the mobile application and platform .

  • January 2019

    Buyback of tokens from members who received them as a bonus for using the platform

    (patients, medical centers, doctors) .

  • February 2019

    Signing contracts describing the form of work with Ministries of Health in countries where the

    platform is operating, further promotion of the platform around the world. 

  • March 2019

    The choice of an exchange for the IPO.

  • April - June 2019

    Negotiations with underwriters on the terms of listing on the exchange.

  • July 2019 - January 2020

    Creation of a legal framework to carry out an IPO

  • January 2020

    Buyback of tokens from members who received them as a bonus for using the platform

    (patients, medical centers, doctors).

  • January - March 2020

    Creation of a Joint Stock Company .

  • April - October 2020

    Creation of a technical and legal framework, as well as working with banks, underwriters

    working on the IPO, auditing the company to determine capitalisation and asset prices of the

    Joint Stock Company.

  • January 2021

    IPO, distribution of shares to token holders and a listing of tokens on exchanges .

  • January 2022

    The first payment of dividends to shareholders.

White Paper

Investment Info
Accepting BTC, ETH, LTC, BCH, Fiat
Token Info
Country Spain
Hardcap $ 15,000,000 USD
Softcap $ 3,000,000 USD
Token ATL
Platform Ethereum
Type ERC20
Token Price 1 ATL = 0.0001 ETH
Token Count 250,000,000
Pre-Sale Start Date
Pre-Sale End Date
Crowd Sale Start Date 2018-08-11
Crowd Sale End Date 2018-10-31

Write a review

Note: HTML is not translated!
    Bad           Good
This ICO is being reviewed in detail. This section will be updated soon.